prof. dr. Philippe Gevaert

Journal Article
A1
open access

Dupilumab reduces systemic corticosteroid use and sinonasal surgery rate in CRSwNP

M. Desrosiers, L.P. Mannent, N. Amin, G.W. Canonica, Peter Hellings (UGent) , Philippe Gevaert (UGent) , J. Mullol, S.E. Lee, S. Fujieda, J.K. Han, et al.

(2021) RHINOLOGY. 59(3). p.301-311

Add to list

Miscellaneous

Mepolizumab for chronic rhinosinusitis with nasal polyps

Guy Brusselle (UGent) and Philippe Gevaert (UGent)

(2021) LANCET RESPIRATORY MEDICINE. 9(10). p.1081-1082

Add to list

Mepolizumab improves health related quality of life for patients with chronic rhinosinusitis with nasal polyps : data from the SYNAPSE study

Stella Lee, Maggie Tabberer, Andrew Trigg, Joseph Han, Wytske Fokkens, Robert Naclerio, Philippe Gevaert (UGent) , Ana Sousa, Peter Howarth, Bhabita Mayer, et al.

(2021) JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY. 147(2). p.AB125-AB125

Add to list

Management of patients with chronic rhinosinusitis during the COVID-19 pandemic : an EAACI position paper

Ludger Klimek, Marek Jutel, Jean Bousquet, Ioana Agache, Cezmi A. Akdis, Valerie Hox, Philippe Gevaert (UGent) , Peter Valentin Tomazic, Carmen Rondon, Cemal Cingi, et al.

(2021) ALLERGY. 76(3). p.677-688

Add to list

A 300 IR sublingual tablet is an effective, safe treatment for house dust mite induced allergic rhinitis : an international, double-blind, placebo-controlled, randomized phase III clinical trial

Pascal Demoly, Jonathan Corren, Peter Creticos, Frederic De Blay, Philippe Gevaert (UGent) , Peter Hellings (UGent) , Krzysztof Kowal, Martine Le Gall, Natalia Nenasheva, Giovanni Passalacqua, et al.

(2021) JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY. 147(3). p.1020-1030.e10

Add to list

Efficacy and safety of treatment with biologicals for severe chronic rhinosinusitis with nasal polyps : a systematic review for the EAACI guidelines

Ioana Agache, Yang Song, Pablo Alonso-Coello, Yasmin Vogel, Claudio Rocha, Ivan Sola, Marilina Santero, Cezmi Akdis, Mubeccel Akdis, Giorgio Walter Canonica, et al.

(2021) ALLERGY. 76(8). p.2337-2353

Add to list

EUFOREA expert board meeting on uncontrolled severe chronic rhinosinusitis with nasal polyps (CRSwNP) and biologics : definitions and management

Claus Bachert (UGent) , Joe K. Han, Martin Wagenmann, Werner Hosemann, Stella E. Lee, Vibeke Backer, Joaquim Mullol, Philippe Gevaert (UGent) , Ludger Klimek, Emanuel Prokopakis, et al.

(2021) JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY. 147(1). p.29-36

Add to list

Surgery in nasal polyp patients : outcome after a minimum observation of 10 years

Stephan Vlaminck (UGent) , Frederic Acke (UGent) , Emmanuel Prokopakis, Kato Speleman, Hideyuki Kawauchi, Jean-Christophe van Cutsem, Peter Hellings (UGent) , Mark Jorissen, Sven Seys, Claus Bachert (UGent) , et al.

(2021) AMERICAN JOURNAL OF RHINOLOGY & ALLERGY. 35(4). p.449-457

Add to list

Omalizumab or dupilumab for chronic rhinosinusitis with nasal polyposis Reply

Philippe Gevaert (UGent) , Jonathan Corren, Joaquim Mullol, Joseph Han, Stella E. Lee, Monica Ligueros-Saylan, Kit Wong, Theodore A. Omachi and Claus Bachert (UGent)

(2021) JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY. 147(1). p.413-414

Add to list

ARIA digital anamorphosis : digital transformation of health and care in airway diseases from research to practice

Jean Bousquet, Josep M. Anto, Claus Bachert (UGent) , Tari Haahtela, Torsten Zuberbier, Wienczyslawa Czarlewski, Anna Bedbrook, Sinthia Bosnic-Anticevich, G. Walter Canonica, Victoria Cardona, et al.

(2021) ALLERGY. 76(1). p.168-190

Academic Bibliography

prof. dr. Philippe Gevaert

Dupilumab reduces systemic corticosteroid use and sinonasal surgery rate in CRSwNP

Mepolizumab for chronic rhinosinusitis with nasal polyps

Mepolizumab improves health related quality of life for patients with chronic rhinosinusitis with nasal polyps : data from the SYNAPSE study

Management of patients with chronic rhinosinusitis during the COVID-19 pandemic : an EAACI position paper

A 300 IR sublingual tablet is an effective, safe treatment for house dust mite induced allergic rhinitis : an international, double-blind, placebo-controlled, randomized phase III clinical trial

Efficacy and safety of treatment with biologicals for severe chronic rhinosinusitis with nasal polyps : a systematic review for the EAACI guidelines

EUFOREA expert board meeting on uncontrolled severe chronic rhinosinusitis with nasal polyps (CRSwNP) and biologics : definitions and management

Surgery in nasal polyp patients : outcome after a minimum observation of 10 years

Omalizumab or dupilumab for chronic rhinosinusitis with nasal polyposis Reply

ARIA digital anamorphosis : digital transformation of health and care in airway diseases from research to practice

Contents

Support

Contact